Suven Pharmaceuticals get final approval to amalgamate Cohance Lifesciences
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
The product will be marketed by Dr. Reddy's
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
Subscribe To Our Newsletter & Stay Updated